Galectin signature in normal pregnancy and preeclampsia
Members of the galectin family are expressed within the female reproductive tract and have been shown to be involved in multiple biological functions that support the progression of pregnancy. Specific expression patterns of different members of this family have been identified at the maternal decid...
Guardado en:
| Autor principal: | |
|---|---|
| Otros Autores: | |
| Formato: | Capítulo de libro |
| Lenguaje: | Inglés |
| Publicado: |
Elsevier Ireland Ltd
2014
|
| Materias: | |
| Acceso en línea: | Registro en Scopus DOI Handle Registro en la Biblioteca Digital |
| Aporte de: | Registro referencial: Solicitar el recurso aquí |
| LEADER | 19059caa a22017417a 4500 | ||
|---|---|---|---|
| 001 | PAPER-14487 | ||
| 003 | AR-BaUEN | ||
| 005 | 20230518204501.0 | ||
| 008 | 190411s2014 xx ||||fo|||| 00| 0 eng|d | ||
| 024 | 7 | |2 scopus |a 2-s2.0-84897640129 | |
| 040 | |a Scopus |b spa |c AR-BaUEN |d AR-BaUEN | ||
| 030 | |a JRIMD | ||
| 100 | 1 | |a Blois, S.M. | |
| 245 | 1 | 0 | |a Galectin signature in normal pregnancy and preeclampsia |
| 260 | |b Elsevier Ireland Ltd |c 2014 | ||
| 270 | 1 | 0 | |m Blois, S.M.; Universitätsmedizin Berlin, Charité-Center 12 Internal Medicine and Dermatology, Reproductive Medicine Research Group, Berlin, Germany; email: sandra.blois@charite.de |
| 506 | |2 openaire |e Política editorial | ||
| 504 | |a Alves, C.M., Galectin-3 plays a modulatory role in the life span and activation of murine neutrophils during early toxoplasma gondii infection (2010) Immunobiology, 215, pp. 475-485 | ||
| 504 | |a Balogh, A., Placental protein 13 (pp13/galectin-13) undergoes lipid raft-associated subcellular redistribution in the syncytiotrophoblast in preterm preeclampsia and HELLP syndrome (2011) Am. J. Obstet. Gynecol., 205 (15), pp. e1-e14 | ||
| 504 | |a Barondes, S.H., Galectins. Structure and function of a large family of animal lectins (1994) J. Biol. Chem., 269, pp. 20807-20810 | ||
| 504 | |a Blois, S.M., A pivotal role for galectin-1 in fetomaternal tolerance (2007) Nat. Med., 13, pp. 1450-1457 | ||
| 504 | |a Brewer, C.F., Clusters, bundles, arrays and lattices: novel mechanisms for lectin-saccharide-mediated cellular interactions (2002) Curr. Opin. Struct. Biol., 12, pp. 616-623 | ||
| 504 | |a Camby, I., Galectin-1: a small protein with major functions (2006) Glycobiology, 16, pp. 137R-157R | ||
| 504 | |a Carlino, C., Recruitment of circulating nk cells through decidual tissues: a possible mechanism controlling nk cell accumulation in the uterus during early pregnancy (2008) Blood, 111, pp. 3108-3115 | ||
| 504 | |a Cattaneo, V., Galectin-8 tandem-repeat structure is essential for t-cell proliferation but not for co-stimulation (2011) Biochem. J., 434, pp. 153-160 | ||
| 504 | |a Chen, H.Y., Roles of galectin-3 in immune responses (2005) Arch. Immunol. Ther. Exp., 53, pp. 497-504 | ||
| 504 | |a Choe, Y.S., Expression of galectin-1 mRNA in the mouse uterus is under the control of ovarian steroids during blastocyst implantation (1997) Mol. Reprod. Dev., 48, pp. 261-266 | ||
| 504 | |a Cindrova-Davies, T., Oxidative stress, gene expression, and protein changes induced in the human placenta during labor (2007) Am. J. Pathol., 171, pp. 1168-1179 | ||
| 504 | |a Colnot, C., Embryonic implantation in galectin 1/galectin 3 double mutant mice (1998) Dev. Dyn., 211, pp. 306-313 | ||
| 504 | |a Cooper, D.N., Galectinomics: finding themes in complexity (2002) Biochim. Biophys. Acta, 1572, pp. 209-231 | ||
| 504 | |a Cordo-Russo, R.I., HA in pathological and physiological processes: An overview of HA metabolism in cancer and pregnancy (2012) Curr. Trend. in Immunol, 13, pp. 81-94 | ||
| 504 | |a Crider-Pirkle, S., Cubilin, a binding partner for galectin-3 in the murine utero-placental complex (2002) J. Biol. Chem., 277, pp. 15904-15912 | ||
| 504 | |a Delgado, V.M., Modulation of endothelial cell migration and angiogenesis: a novel function for the Tandem-repeat Lectin galectin-8 (2011) FASEB J., 25, pp. 242-254 | ||
| 504 | |a Dong, M., The effect of trophoblasts on t lymphocytes: possible regulatory effector molecules - a proteomic analysis (2008) Cell. Physiol. Biochem., 21, pp. 463-472 | ||
| 504 | |a Douglas, N.C., Vascular endothelial growth factor receptor 2 (VEGFR-2) functions to promote uterine decidual angiogenesis during early pregnancy in the mouse (2009) Endocrinology, 150, pp. 3845-3854 | ||
| 504 | |a Eshkar Sebban, L., The involvement of CD44 and its novel ligand galectin-8 in apoptotic regulation of autoimmune inflammation (2007) J. Immunol., 179, pp. 1225-1235 | ||
| 504 | |a Farina, A., Performance of messenger rNAS circulating in maternal blood in the prediction of preeclampsia at 10-14 weeks (2010) Am. J. Obstet. Gynecol., 203 (57), pp. e1-e7 | ||
| 504 | |a Froehlich, R., Galectin fingerprinting detects differences in expression profiles between bovine endometrium and placentomes as well as early and late gestational stages (2012) Placenta, 33, pp. 195-201 | ||
| 504 | |a Gizurarson, S., Effects of placental protein 13 on the cardiovascular system in gravid and non-gravid rodents (2013) Fetal Diagn. Ther., 33, pp. 257-264 | ||
| 504 | |a Halder, J.B., Differential expression of VEGF isoforms and VEGF(164)-specific receptor neuropilin-1 in the mouse uterus suggests a role for VEGF(164) in vascular permeability and angiogenesis during implantation (2000) Genesis, 26, pp. 213-224 | ||
| 504 | |a Harskamp, R.E., Zeeman, G.G., Preeclampsia: at risk for remote cardiovascular disease (2007) Am. J. Med. Sci., 334, pp. 291-295 | ||
| 504 | |a Hernandez, J.D., Baum, L.G., Ah sweet mystery of death! Galectins and control of cell fate (2002) Glycobiology, 12, pp. 127R-136R | ||
| 504 | |a Herse, F., Cytochrome p450 subfamily 2j polypeptide 2 expression and circulating epoxyeicosatrienoic metabolites in preeclampsia (2012) Circulation, 126, pp. 2990-2999 | ||
| 504 | |a Heusschen, R., Profiling lgals9 splice variant expression at the fetal-maternal interface: implications in normal and pathological human pregnancy (2013) Biol. Reprod., 88, p. 22 | ||
| 504 | |a Hirota, Y., Galectin-1 markedly reduces the incidence of resorptions in mice missing immunophilin fkbp52 (2012) Endocrinology, 153, pp. 2486-2493 | ||
| 504 | |a Hsieh, S.H., Galectin-1 a novel ligand of neuropilin-1, activates VEGFR-2 signaling and modulates the migration of vascular endothelial cells (2008) Oncogene, 27, pp. 3746-3753 | ||
| 504 | |a Huppertz, B., Placental origins of preeclampsia: challenging the current hypothesis (2008) Hypertension, 51, pp. 970-975 | ||
| 504 | |a Huppertz, B., Placental protein 13 (PP13): a new biological target shifting individualized risk assessment to personalized drug design combating pre-eclampsia (2013) Hum. Reprod. Update, 19, pp. 391-405 | ||
| 504 | |a Iglesias, M.M., Purification of galectin-3 from ovine placenta: developmentally regulated expression and immunological relevance (1998) Glycobiology, 8, pp. 59-65 | ||
| 504 | |a Jeschke, U., Expression of galectin-1, -3 (gal-1, gal-3) and the Thomsen-Friedenreich (TF) antigen in normal IUGR, preeclamptic and HELLP placentas (2007) Placenta, 28, pp. 1165-1173 | ||
| 504 | |a Kliman, H.J., Placental protein 13 and decidual zones of necrosis: an immunologic diversion that may be linked to preeclampsia (2012) Reprod. Sci., 19, pp. 16-30 | ||
| 504 | |a Kolundzic, N., Galectin-1 is part of human trophoblast invasion machinery - a functional study in vitro (2011) PLoS ONE, 6, pp. e28514 | ||
| 504 | |a Kolundzic, N., Galectin-8 is expressed by villous and extravillous trophoblast of the human placenta (2011) Placenta, 32, pp. 909-911 | ||
| 504 | |a Koopman, L.A., Human decidual natural killer cells are a unique NK cell subset with immunomodulatory potential (2003) J. Exp. Med., 198, pp. 1201-1212 | ||
| 504 | |a Kopcow, H.D., T cell apoptosis at the maternal-fetal interface in early human pregnancy involvement of galectin-1 (2008) Proc. Natl. Acad. Sci. U. S. A., 105, pp. 18472-18477 | ||
| 504 | |a Kuang, H., Hormonal regulation of uterine natural killer cells in mouse preimplantation uterus (2010) J. Mol. Histol., 41, pp. 1-7 | ||
| 504 | |a Lindheimer, M.D., Ash position paper: hypertension in pregnancy (2009) J. Clin. Hypertens. (Greenwich), 11, pp. 214-225 | ||
| 504 | |a Liu, A.X., Proteomic analysis on the alteration of protein expression in the placental villous tissue of early pregnancy loss (2006) Biol. Reprod., 75, pp. 414-420 | ||
| 504 | |a Liu, F.T., Intracellular functions of galectins (2002) Biochim. Biophys. Acta, 1572, pp. 263-273 | ||
| 504 | |a Maquoi, E., Changes in the distribution pattern of galectin-1 and galectin-3 in human placenta correlates with the differentiation pathways of trophoblasts (1997) Placenta, 18, pp. 433-439 | ||
| 504 | |a Moffett-King, A., Natural killer cells and pregnancy (2002) Nat. Rev. Immunol., 2, pp. 656-663 | ||
| 504 | |a Molvarec, A., Peripheral blood galectin-1-expressing T and natural killer cells in normal pregnancy and preeclampsia (2011) Clin. Immunol., 139, pp. 48-56 | ||
| 504 | |a Nickel, W., Unconventional secretory routes: direct protein export across the plasma membrane of mammalian cells (2005) Traffic, 6, pp. 607-614 | ||
| 504 | |a Nicolaides, K.H., A novel approach to first-trimester screening for early pre-eclampsia combining serum PP-13 and Doppler ultrasound (2006) Ultrasound Obstet. Gynecol., 27, pp. 13-17 | ||
| 504 | |a Nishi, N., Galectin-8 modulates neutrophil function via interaction with integrin alpham (2003) Glycobiology, 13, pp. 755-763 | ||
| 504 | |a Ogawa, M., Paradoxical discrepancy between the serum level and the placental intensity of PP5/TFPI-2 in preeclampsia and/or intrauterine growth restriction: possible interaction and correlation with glypican-3 hold the key (2007) Placenta, 28, pp. 224-232 | ||
| 504 | |a Oomizu, S., Galectin-9 suppresses Th17 cell development in an IL-2-dependent but TIM-3-independent manner (2012) Clin. Immunol., 143, pp. 51-58 | ||
| 504 | |a Phillips, B., Differential expression of two beta-galactoside-binding lectins in the reproductive tracts of pregnant mice (1996) Biol. Reprod., 55, pp. 548-558 | ||
| 504 | |a Popovici, R.M., Galectin-9: a new endometrial epithelial marker for the mid- and late-secretory and decidual phases in humans (2005) J. Clin. Endocrinol. Metab., 90, pp. 6170-6176 | ||
| 504 | |a Powe, C.E., Preeclampsia, a disease of the maternal endothelium: the role of antiangiogenic factors and implications for later cardiovascular disease (2011) Circulation, 123, pp. 2856-2869 | ||
| 504 | |a Rabinovich, G.A., An emerging role for galectins in tuning the immune response: lessons from experimental models of inflammatory disease, autoimmunity and cancer (2007) Scand. J. Immunol., 66, pp. 143-158 | ||
| 504 | |a Redman, C.W., Immunological aspects of pre-eclampsia (1992) Baillieres Clin. Obstet. Gynaecol., 6, pp. 601-615 | ||
| 504 | |a Redman, C.W., Sargent, I.L., Circulating microparticles in normal pregnancy and pre-eclampsia (2008) Placenta, 29 (SUPPL A), pp. S73-S77 | ||
| 504 | |a Redman, C.W., Sargent, I.L., Placental stress and pre-eclampsia: a revised view (2009) Placenta, 30 (SUPPL A), pp. S38-S42 | ||
| 504 | |a Redman, C.W., Sargent, I.L., Immunology of pre-eclampsia (2010) Am. J. Reprod. Immunol., 63, pp. 534-543 | ||
| 504 | |a Redman, C.W., Preeclampsia: an excessive maternal inflammatory response to pregnancy (1999) Am. J. Obstet. Gynecol., 180, pp. 499-506 | ||
| 504 | |a Sammar, M., Placenta-bound and body fluid PP13 and its MRNA in normal pregnancy compared to preeclampsia, HELLP and preterm delivery (2011) Placenta, 32 (SUPPL), pp. S30-S36 | ||
| 504 | |a Sargent, I.L., Immunoregulation in normal pregnancy and pre-eclampsia: an overview (2007) Reprod. Biomed. Online, 14, pp. 111-117. , Spec No. 1 | ||
| 504 | |a Sekizawa, A., PP13 MRNA expression in trophoblasts from preeclamptic placentas (2009) Reprod. Sci., 16, pp. 408-413 | ||
| 504 | |a Shimizu, H., PP13 MRNA expression in the cellular component of maternal blood as a marker for preeclampsia (2009) Prenat. Diagn., 29, pp. 1231-1236 | ||
| 504 | |a Sibai, B.M., Severe preeclampsia in the second trimester: recurrence risk and long-term prognosis (1991) Am. J. Obstet. Gynecol., 165, pp. 1408-1412 | ||
| 504 | |a Sibai, B.M., Preeclampsia as a cause of preterm and late preterm (near-term) births (2006) Semin. Perinatol., 30, pp. 16-19 | ||
| 504 | |a Staff, A.C., Redefining preeclampsia using placenta-derived biomarkers (2013) Hypertension, 61, pp. 932-942 | ||
| 504 | |a Stillman, B.N., Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce t cell death (2006) J. Immunol., 176, pp. 778-789 | ||
| 504 | |a Than, N.G., Isolation and sequence analysis of a cdna encoding human placental tissue protein 13 (pp13) a new lysophospholipase, homologue of human eosinophil charcot-leyden crystal protein (1999) Placenta, 20, pp. 703-710 | ||
| 504 | |a Than, N.G., Functional analyses of placental protein 13/galectin-13 (2004) Eur. J. Biochem., 271, pp. 1065-1078 | ||
| 504 | |a Than, N.G., Placental protein 13 (galectin-13) has decreased placental expression but increased shedding and maternal serum concentrations in patients presenting with preterm pre-eclampsia and HELLP syndrome (2008) Virchows Arch., 453, pp. 387-400 | ||
| 504 | |a Than, N.G., Severe preeclampsia is characterized by increased placental expression of galectin-1 (2008) J. Matern. Fetal Neonatal Med., 21, pp. 429-442 | ||
| 504 | |a Than, N.G., A primate subfamily of galectins expressed at the maternal-fetal interface that promote immune cell death (2009) Proc. Natl. Acad. Sci. U. S. A., 106, pp. 9731-9736 | ||
| 504 | |a Thijssen, V.L., The galectin profile of the endothelium: altered expression and localization in activated and tumor endothelial cells (2008) Am. J. Pathol., 172, pp. 545-553 | ||
| 504 | |a Thijssen, V.L., Tumor cells secrete galectin-1 to enhance endothelial cell activity (2010) Cancer Res., 70, pp. 6216-6224 | ||
| 504 | |a Tirado-Gonzalez, I., Galectin-1 influences trophoblast immune evasion and emerges as a predictive factor for the outcome of pregnancy (2013) Mol. Hum. Reprod., 19, pp. 43-53 | ||
| 504 | |a Tribulatti, M.V., Redundant and antagonistic functions of galectin-1, -3, and -8 in the elicitation of t cell responses (2012) J. Immunol., 188, pp. 2991-2999 | ||
| 504 | |a Vicovac, L., Galectin-1 and -3 in cells of the first trimester placental bed (1998) Hum. Reprod., 13, pp. 730-735 | ||
| 504 | |a Vince, G.S., Interleukin-6 tumour necrosis factor and soluble tumour necrosis factor receptors in women with pre-eclampsia (1995) Br. J. Obstet. Gynaecol., 102, pp. 20-25 | ||
| 504 | |a Von Dadelszen, P., Subclassification of preeclampsia (2003) Hypertens Pregnancy, 22, pp. 143-148 | ||
| 504 | |a Von Wolff, M., Galectin fingerprinting in human endometrium and decidua during the menstrual cycle and in early gestation (2005) Mol. Hum. Reprod., 11, pp. 189-194 | ||
| 504 | |a Wortelboer, E.J., First-trimester placental protein 13 and placental growth factor: markers for identification of women destined to develop early-onset pre-eclampsia (2010) BJOG, 117, pp. 1384-1389 | ||
| 504 | |a Yamamoto, H., Induction of cell adhesion by galectin-8 and its target molecules in Jurkat T-cells (2008) J. Biochem., 143, pp. 311-324 | ||
| 504 | |a Yang, H., Expression of galectin-3 in mouse endometrium and its effect during embryo implantation (2012) Reprod. Biomed. Online, 24, pp. 116-122 | ||
| 504 | |a Yang, R.Y., Expression of galectin-3 modulates T-cell growth and apoptosis (1996) Proc. Natl. Acad. Sci. U.S.A., 93, pp. 6737-6742 | ||
| 504 | |a Zhao, X.Y., Synergistic induction of galectin-1 by ccaat/enhancer binding protein alpha and hypoxia-inducible factor 1alpha and its role in differentiation of acute myeloid leukemic cells (2011) J. Biol. Chem., 286, pp. 36808-36819 | ||
| 504 | |a Zhu, C., TIM-3 and its regulatory role in immune responses (2011) Curr. Top. Microbiol. Immunol., 350, pp. 1-15 | ||
| 504 | |a Zick, Y., Role of galectin-8 as a modulator of cell adhesion and cell growth (2004) Glycoconj. J., 19, pp. 517-526 | ||
| 520 | 3 | |a Members of the galectin family are expressed within the female reproductive tract and have been shown to be involved in multiple biological functions that support the progression of pregnancy. Specific expression patterns of different members of this family have been identified at the maternal decidua and on the placental side. In some cases, mechanisms by which galectins exert their functions have been delineated in adverse pregnancy outcomes. This review summarizes studies on galectins that have been documented to be important for pregnancy maintenance, either supporting the maternal adaptation to pregnancy or the placentation process. In addition, we focus our discussion on the role of galectins in preeclampsia, a specific life-threatening pregnancy disorder. © 2013 Elsevier Ireland Ltd. |l eng | |
| 536 | |a Detalles de la financiación: Fritz Thyssen Stiftung, Az. 10.10.2.125 | ||
| 536 | |a Detalles de la financiación: Consejo Nacional de Investigaciones Científicas y Técnicas | ||
| 536 | |a Detalles de la financiación: We apologize to the many authors whose excellent papers could not be cited in this review because of space limitations. The authors are grateful to Prof. Anne Cathrine Staff (Oslo University, Norway) for her critical comments on the article. G.B. received a post-doctoral fellowship from the CONICET. The work discussed in this review was supported by the Fritz Thyssen Stiftung (Az. 10.10.2.125) to S.M.B. | ||
| 593 | |a Universitätsmedizin Berlin, Charité-Center 12 Internal Medicine and Dermatology, Reproductive Medicine Research Group, Berlin, Germany | ||
| 593 | |a Laboratorio de Fisiología Molecular Placentaria, Instituto de Química Biológica, Facultad de Ciencias Exactas y Naturales, Universidad de Buenos Aires, CONICET, Buenos Aires, Argentina | ||
| 690 | 1 | 0 | |a ANGIOGENESIS |
| 690 | 1 | 0 | |a GALECTINS |
| 690 | 1 | 0 | |a PLACENTATION |
| 690 | 1 | 0 | |a PREECLAMPSIA |
| 690 | 1 | 0 | |a GALECTIN |
| 690 | 1 | 0 | |a ARTICLE |
| 690 | 1 | 0 | |a DECIDUA |
| 690 | 1 | 0 | |a HUMAN |
| 690 | 1 | 0 | |a NONHUMAN |
| 690 | 1 | 0 | |a PREECLAMPSIA |
| 690 | 1 | 0 | |a PREGNANCY |
| 690 | 1 | 0 | |a PREGNANCY OUTCOME |
| 690 | 1 | 0 | |a PRIORITY JOURNAL |
| 690 | 1 | 0 | |a PROTEIN EXPRESSION |
| 690 | 1 | 0 | |a REPRODUCTION |
| 690 | 1 | 0 | |a ANGIOGENESIS |
| 690 | 1 | 0 | |a GALECTINS |
| 690 | 1 | 0 | |a PLACENTATION |
| 690 | 1 | 0 | |a PREECLAMPSIA |
| 690 | 1 | 0 | |a DECIDUA |
| 690 | 1 | 0 | |a FEMALE |
| 690 | 1 | 0 | |a GALECTINS |
| 690 | 1 | 0 | |a GENE EXPRESSION REGULATION |
| 690 | 1 | 0 | |a HUMANS |
| 690 | 1 | 0 | |a PRE-ECLAMPSIA |
| 690 | 1 | 0 | |a PREGNANCY |
| 690 | 1 | 0 | |a PREGNANCY OUTCOME |
| 690 | 1 | 0 | |a TRANSCRIPTOME |
| 650 | 1 | 7 | |2 spines |a PLACENTA |
| 700 | 1 | |a Barrientos, G. | |
| 773 | 0 | |d Elsevier Ireland Ltd, 2014 |g v. 101-102 |h pp. 127-134 |k n. 1 |p J. Reprod. Immunol. |x 01650378 |t Journal of Reproductive Immunology | |
| 856 | 4 | 1 | |u https://www.scopus.com/inward/record.uri?eid=2-s2.0-84897640129&doi=10.1016%2fj.jri.2013.05.005&partnerID=40&md5=4a51060022968ca29882abd196b9d8ea |y Registro en Scopus |
| 856 | 4 | 0 | |u https://doi.org/10.1016/j.jri.2013.05.005 |y DOI |
| 856 | 4 | 0 | |u https://hdl.handle.net/20.500.12110/paper_01650378_v101-102_n1_p127_Blois |y Handle |
| 856 | 4 | 0 | |u https://bibliotecadigital.exactas.uba.ar/collection/paper/document/paper_01650378_v101-102_n1_p127_Blois |y Registro en la Biblioteca Digital |
| 961 | |a paper_01650378_v101-102_n1_p127_Blois |b paper |c PE | ||
| 962 | |a info:eu-repo/semantics/article |a info:ar-repo/semantics/artículo |b info:eu-repo/semantics/publishedVersion | ||
| 999 | |c 75440 | ||